S Perwez Hussain
Overview
Explore the profile of S Perwez Hussain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
3473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moreno P, Ohara Y, Craig A, Liu H, Yang S, Dorsey T, et al.
Carcinogenesis
. 2024 Aug;
45(11):845-856.
PMID: 39136088
Pancreatic ductal adenocarcinoma (PDAC) manifests diverse molecular subtypes, including the classical/progenitor and basal-like/squamous subtypes, with the latter known for its aggressiveness. We employed integrative transcriptome and metabolome analyses to identify...
2.
Moreno P, Ohara Y, Craig A, Liu H, Yang S, Zhang L, et al.
bioRxiv
. 2024 Jun;
PMID: 38903083
Pancreatic ductal adenocarcinoma (PDAC) manifests diverse molecular subtypes, including the classical/progenitor and basal-like/squamous subtypes, with the latter known for its aggressiveness. We employed integrative transcriptome and metabolome analyses to identify...
3.
Ohara Y, Liu H, Craig A, Yang S, Moreno P, Dorsey T, et al.
Int J Cancer
. 2024 Apr;
155(3):569-581.
PMID: 38630934
Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease with distinct molecular subtypes described as classical/progenitor and basal-like/squamous PDAC. We hypothesized that integrative transcriptome and metabolome approaches can identify candidate genes...
4.
Ohara Y, Craig A, Liu H, Yang S, Moreno P, Dorsey T, et al.
Carcinogenesis
. 2024 Feb;
45(7):475-486.
PMID: 38366633
Pancreatic ductal adenocarcinoma (PDAC) encompasses diverse molecular subtypes, including the classical/progenitor and basal-like/squamous subtypes, each exhibiting distinct characteristics, with the latter known for its aggressiveness. We employed an integrative approach...
5.
Ohara Y, Tang W, Liu H, Yang S, Dorsey T, Cawley H, et al.
Cell Rep
. 2023 Nov;
42(12):113434.
PMID: 37980563
Pancreatic ductal adenocarcinoma (PDAC) exhibits distinct molecular subtypes: classical/progenitor and basal-like/squamous. Our study aimed to identify genes contributing to the development of the basal-like/squamous subtype, known for its aggressiveness. Transcriptome...
6.
Yang S, Tang W, Azizian A, Gaedcke J, Strobel P, Wang L, et al.
Carcinogenesis
. 2022 Nov;
43(12):1198-1210.
PMID: 36426859
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy and is largely refractory to available treatments. Identifying key pathways associated with disease aggressiveness and therapeutic resistance may characterize candidate targets to...
7.
Parker A, Toulabi L, Oike T, Kanke Y, Patel D, Tada T, et al.
J Clin Invest
. 2022 Jul;
132(14).
PMID: 35838048
The metabolic dependencies of cancer cells have substantial potential to be exploited to improve the diagnosis and treatment of cancer. Creatine riboside (CR) is identified as a urinary metabolite associated...
8.
Ohara Y, Valenzuela P, Hussain S
Trends Cancer
. 2022 May;
8(7):556-569.
PMID: 35525794
Pancreatic ductal adenocarcinoma (PDAC) is characterized by its highly reactive inflammatory desmoplastic stroma with evidence of an extensive tumor stromal interaction largely mediated by inflammatory factors. KRAS mutation and inflammatory...
9.
Zurer I, Hofseth L, Cohen Y, Xu-Welliver M, Hussain S, Harris C, et al.
Carcinogenesis
. 2021 May;
42(6):903.
PMID: 33991083
No abstract available.
10.
Li X, Pongor L, Tang W, Das S, Muys B, Jones M, et al.
Elife
. 2020 Oct;
9.
PMID: 33112233
Long noncoding RNAs (lncRNAs) are often associated with polysomes, indicating coding potential. However, only a handful of endogenous proteins encoded by putative lncRNAs have been identified and assigned a function....